Killu Sanborn

Investor type:

Social media:

Available after registration.

Past investments

  • Bi02 Medical
  • Epic Healthcare Staffing
  • Cardiac Dimensions
  • Syros Pharmaceuticals
  • Navidea Biopharmaceuticals
  • Larimar Therapeutics
  • Asensus Surgical
  • CardioFocus
  • Monteris Medical
  • Minerva Neuroscience
  • Durect Corp.
  • Karius
  • Proteus Digital Health
  • Ignyta
  • Zyga Technology
  • Sonendo
  • SpendMend
  • Eiger BioPharmaceuticals
  • RxSight
  • Avantis Medical Systems
  • HTG Molecular Diagnostics
  • Regulus Therapeutics
  • Ceterix Orthopaedics
  • Tarsa Therapeutics
  • Omeros
  • ConforMIS
  • Ocera Therapeutics
  • Cerapedics
  • Aratana Therapeutics
  • MolecuLight
  • Edgemont Pharmaceuticals
  • Pulmonx
  • Nevakar
  • RF Surgical Systems
  • Xeris Pharmaceuticals
  • Reata Pharmaceuticals
  • Nuvectra
  • MDRejuvena
  • PrimeSource Healthcare Systems
  • Venus Concept
  • QuVa Pharma
  • Conventus Orthopaedics
  • Relypsa
  • Halozyme Therapeutics
  • Singulex
  • Oxford BioTherapeutics
  • Genapsys
  • NanoString Technologies
  • Superior Biologics
  • Codex DNA
  • CymaBay Therapeutics
  • Auspex Pharmaceuticals
  • Puma Biotechnology
  • ReShape Lifesciences
  • Plus Therapeutics
  • Veran Medical Technologies
  • Selecta Biosciences
  • Apollo Endosurgery
  • Labcyte
  • Avanir Pharmaceuticals
  • Senseonics
  • Amicus Therapeutics
  • Immunocore
  • Continuum Healthcare
  • Continuing Healthcare Solutions
  • Horizon Therapeutics
  • Castle Biosciences
  • VitalConnect
  • ReMed
  • Celula
  • Tobira Therapeutics
  • Nature’s Fynd
  • RefleXion Medical
  • Cerus
  • CVRx
  • Keystone Dental
  • Summit Healthcare REIT
  • TMS NeuroHealth Centers Tysons Corner
  • AliveCor
  • CareDx
  • Intellicyt
  • AirXpanders
  • NeoVista
  • Cardiff Oncology
  • diaDexus
  • LensAR
  • InterValve
  • Acura Pharmaceuticals
  • SynergEyes
  • Ceptaris Therapeutics
  • ObsEva
  • AlterG